A retrospective analysis of pharmacokinetic/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin

被引:20
|
作者
Sánchez-Recio, MM [1 ]
Colino, CI [1 ]
Sánchez-Navarro, A [1 ]
机构
[1] Univ Salamanca, Fac Farm, Dept Farm & Tecnol Farmaceut, E-37007 Salamanca, Spain
关键词
D O I
10.1093/jac/45.3.321
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A retrospective analysis of the relationship between estimated pharmacokinetic/pharmacodynamic indices and the reported efficacy of ciprofloxacin has been carried out using different correlation models. C-max(SS)/MIC, T-SS > MIC, (AUC(SS))/MIC and AUIC(SS) were calculated for each clinical case included in the study, from simulated plasma level curves corresponding to the dosage regimen administered. A univariate correlation analysis was performed considering efficacy (%) as the dependent variable and indices as the independent variables according to linear and non-linear pharmacokinetic-pharmacodynamic models (PK-PD models),The results prove that log-transformation of the independent variable improves the data fitting to linear model. The four estimated indices show a log-linear relationship with outcome, T-SS > MIC and AUIC(SS) being the parameters best correlated with percentage efficacy. The E-max model with intrinsic response is an additional correlation strategy for T-SS > MIG, leading to estimated values of E-max and E-0 of 100.34 +/- 25.09% and 24.40 +/- 11.7%, respectively. The wide range of bacteria responsible for the infections considered, including Gram-positive pathogens such as staphylococci, might explain the good correlation between T-SS > MIC and percentage efficacy found for ciprofloxacin in this study.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [41] Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients with Enterococcus faecium bacteraemia: a retrospective cohort study
    Tochikura, Naohiro
    Matsumoto, Chiaki
    Iwabuchi, So
    Aso, Hiroya
    Fukushima, Sakae
    Ootsuka, Susumu
    Ooba, Nobuhiro
    Ishihara, Masaki
    Nakajima, Hideto
    Umemura, Hiroshi
    Nakayama, Tomohiro
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (05) : 440 - 446
  • [42] Pharmacokinetic/Pharmacodynamic Determinants of Vancomycin Efficacy in Enterococcal Bacteremia
    Bin Jumah, Muhammed Taufiq
    Vasoo, Shawn
    Menon, Sanjay R.
    De, Partha Pratim
    Neely, Michael
    Teng, Christine B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [43] Corticosteroid pharmacokinetic/pharmacodynamic parameters and their relationship to safety and efficacy
    Derendorf, H
    ALLERGY AND ASTHMA PROCEEDINGS, 2005, 26 (05) : 327 - 335
  • [44] Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline
    Falagas, Matthew E.
    Karageorgopoulos, Drosos E.
    Dimopoulos, George
    CURRENT DRUG METABOLISM, 2009, 10 (01) : 13 - 21
  • [45] Clinical Pharmacokinetic and Pharmacodynamic Profile of Inhaled Ciclesonide
    Nave, Ruediger
    CLINICAL PHARMACOKINETICS, 2009, 48 (04) : 243 - 252
  • [46] Clinical Pharmacokinetic and Pharmacodynamic Profile of Inhaled Ciclesonide
    Rüdiger Nave
    Clinical Pharmacokinetics, 2009, 48 : 243 - 252
  • [47] Pharmacodynamic and Pharmacokinetic Properties of EnoxaparinImplications for Clinical Practice
    Jawed Fareed
    Debra Hoppensteadt
    Jeanine Walenga
    Omer Iqbal
    Qing Ma
    Walter Jeske
    Taqdees Sheikh
    Clinical Pharmacokinetics, 2003, 42 : 1043 - 1057
  • [48] Clinical Pharmacokinetic and Pharmacodynamic Monitoring for Mycophenolate Mofetil
    Ku, Yi-Min
    McCartan, Megan
    Collier, Dean
    JOURNAL OF PHARMACY PRACTICE, 2005, 18 (06) : 422 - 431
  • [49] CLINICAL IMPORTANCE OF PHARMACOKINETIC AND PHARMACODYNAMIC DRUG INTERACTIONS
    KOCHWESER, J
    NETHERLANDS JOURNAL OF MEDICINE, 1977, 20 (02): : 59 - 70
  • [50] Pharmacokinetic and pharmacodynamic changes in the elderly -: Clinical implications
    Hämmerlein, A
    Derendorf, H
    Lowenthal, DT
    CLINICAL PHARMACOKINETICS, 1998, 35 (01) : 49 - 64